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Familial Aggregation of Migraine and Depression:
Insights From a Large Australian Twin Sample
Yuanhao Yang,1 Huiying Zhao,1 Andrew C. Heath,2 Pamela A. F. Madden,2 Nicholas G. Martin,3 and
Dale R. Nyholt1
1
Statistical and Genomic Epidemiology Laboratory, Institute of Health and Biomedical Innovation, Queensland University
of Technology, Brisbane, Queensland, Australia
2
Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, USA
3
Genetic Epidemiology Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

Objectives: This research examined the familial aggregation of migraine, depression, and their cooccurrence.
Methods: Diagnoses of migraine and depression were determined in a sample of 5,319 Australian twins.
Migraine was diagnosed by either self-report, the ID migraineTM Screener, or International Headache
Society (IHS) criteria. Depression was defined by fulfilling either major depressive disorder (MDD) or minor
depressive disorder (MiDD) based on the Diagnostic and Statistical Manual of Mental Disorders (DSM)
criteria. The relative risks (RR) for migraine and depression were estimated in co-twins of twin probands
reporting migraine or depression to evaluate their familial aggregation and co-occurrence.
Results: An increased RR of both migraine and depression in co-twins of probands with the same trait was
observed, with significantly higher estimates within monozygotic (MZ) twin pairs compared to dizygotic
(DZ) twin pairs. For cross-trait analysis, the RR for migraine in co-twins of probands reporting depression
was 1.36 (95% CI: 1.24–1.48) in MZ pairs and 1.04 (95% CI: 0.95–1.14) in DZ pairs; and the RR for depression
in co-twins of probands reporting migraine was 1.26 (95% CI: 1.14–1.38) in MZ pairs and 1.02 (95% CI:
0.94–1.11) in DZ pairs. The RR for strict IHS migraine in co-twins of probands reporting MDD was 2.23
(95% CI: 1.81–2.75) in MZ pairs and 1.55 (95% CI: 1.34–1.79) in DZ pairs; and the RR for MDD in co-twins
of probands reporting IHS migraine was 1.35 (95% CI: 1.13–1.62) in MZ pairs and 1.06 (95% CI: 0.93–1.22)
in DZ pairs.
Conclusions: We observed significant evidence for a genetic contribution to familial aggregation of migraine and depression. Our findings suggest a bi-directional association between migraine and depression,
with an increased risk for depression in relatives of probands reporting migraine, and vice versa. However,
the observed risk for migraine in relatives of probands reporting depression was considerably higher than
the reverse. These results add further support to previous studies suggesting that patients with comorbid
migraine and depression are genetically more similar to patients with only depression than patients with
only migraine.
 Keywords: migraine, depression, relative risk, familial aggregation, bi-directional association

Migraine, a recurrent disabling headache accompanied by
chronic and episodic manifestations, is one of the most
complex neurological disorders (Goadsby et al., 2002). Multiple cross-sectional studies (Ashina et al., 2012; Buse et al.,
2010; Camarda et al., 2008; Fuller-Thomson et al., 2013;
Mercante et al., 2005; Molgat & Patten, 2005; Rist et al.,
2013; Zwart et al., 2003) have consistently observed that
migraine often co-occurs with depression, a psychological
disorder characterized by dramatic decline in both mental
and physical conditions (Remick, 2002).
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Also supported by some Caucasian population-based
longitudinal studies (Breslau et al., 1994; Breslau et al.,
2000; Breslau et al., 2003; Modgill et al., 2012), the association between migraine and depression is considered to
be bi-directional, with migraine or severe headache increasing up to a 3-fold higher population relative risk (RR) of
suffering depression, and vice versa. Another longitudinal
study (Mongini et al., 2003) also revealed a potential bidirectional association between depression and migraine
frequency and severity, while one U.S. study (Swartz et al.,
2000) failed to repeat these results, possibly due to the influence of other comorbid psychological disorders, such as
panic disorder, and social phobia, which were jointly analyzed in the study.
Although repeatedly observed, little is known about the
mechanisms underlying the association between migraine
and depression. An increased RR (i.e., RR > 1) of one trait,
evaluated from twin and family samples, has been identified
in relatives of probands reporting the same trait, for both
migraine (Cologno et al., 2003; Kalfakis et al., 1996; Lemos
et al., 2009; Russell & Olesen, 1995; Stewart et al., 1997;
Stewart et al., 2006; Thomsen et al., 2003) and depression
(Barker et al., 2012; Merikangas et al., 2014; Schreier et al.,
2006; Sullivan et al., 2000; Vandeleur et al., 2014). These
results provide strong evidence on familial aggregation in
migraineurs and depressive patients. The variation in estimated RRs among these studies is likely due to the different
diagnostic approaches and study populations. For instance,
the lifetime prevalence of migraine was calculated as 20–
28% (Al-Hashel et al., 2014; Bicakci et al., 2008; Moens
et al., 2007) based on the ID migraineTM Screener criteria (Lipton et al., 2003) but reduced to approximately 12%
(Buse et al., 2012; Lipton et al., 2001) when based on the
International Headache Society (IHS) criteria (Headache
Classification Committee of the International Headache,
2013); and Caucasian populations had significant higher
migraine and depression morbidity than African and Asian
populations (Riolo et al., 2005; Stewart et al., 1996).
Significant familial aggregation of one trait indicates the
presence of shared genetic and/or environmental factors in
susceptibility of the trait. A considerable genetic contribution can be further determined after excluding environmental factors. Because both monozygotic (MZ) and dizygotic
(DZ) twin pairs share similar living resources and environment, they are considered to experience the same environmental factors. Therefore, the observation of higher RRs
within MZ twin pairs compared to DZ twin pairs provides
evidence for a genetic contribution in susceptibility of the
trait. For example, a significant higher RR for prostate cancer within male MZ pairs (RR = 12.3, 95% CI = 8.4–18.1)
compared to male DZ pairs (RR = 3.1, 95% CI = 1.9–4.9;
Lichtenstein et al., 2000), indicates a significant contribution of genetic factors for the risk of prostate cancer.
The heritability of migraine and depression are both
estimated at approximately 50% (Levinson, 2006; Mulder
TWIN RESEARCH AND HUMAN GENETICS

et al., 2003), indicating both genetic and environmental factors play an important role in their development. Therefore,
extending RR analyses in MZ and DZ twin pairs across both
migraine and depression provides a natural experiment to
determine the existence of shared genetic components between the two traits. Ours is the first such study to use a
large population-based Australian twin sample to examine
the association between migraine and depression.
In this article, we first examine the familial aggregation
of migraine, depression, and their co-occurrence. We next
compare relative risks estimated in MZ twin pairs to those
estimated in DZ twin pairs to provide evidence for the
contribution of genetic factors towards their risk.

Materials and Methods
Samples

As shown in Figure 1, participants were drawn from three
Australian twin cohorts based at QIMR Berghofer Medical
Research Institute (Heath et al., 2001; Wright & Martin,
2004). Subjects with migraine and depression status were
selected and constituted the ‘merged migraine sample’ (N
= 38,279) and ‘merged depression sample’ (N = 60,170)
respectively. Definitions of migraine and depression were
homogenized across the cohorts. Subjects also answered
questions regarding demographic characteristics (e.g., sex,
date of birth, zygosity) via semi-structured telephone interview and/or questionnaire. After combining the two merged
samples and removal of non-twins and twins with missing
status of either migraine or depression, a total of 5,319 twin
pairs (2,456 MZ and 2,863 DZ pairs) remained for analysis.
Assessment of Migraine

Migraine symptom information ranged from single-answer
self-report (yes or no) of migraine, using the ID MigraineTM
Screener (Lipton et al., 2003) — three questions shown to
accurately identify 93% of people with migraines — to
detailed IHS diagnostic criteria (International Classification of Headache Disorders, ICHD-3; Headache Classification Committee of the International Headache, 2013).
For the collection of detailed ICHD-3 diagnostic criteria
(see Table 1), participants answering ‘yes’ to ever having
‘migraine or recurrent attacks of headache’ (screening positive), then answered a number of questions relating to their
symptoms. Diagnoses were determined for the two major
varieties of migraine: 1.1 migraine without aura (MO) and
1.2 migraine with aura (MA, primarily comprising 1.2.1
typical aura with migraine headache), which account for
90–95% of all IHS migraines (Launer et al., 1999).
After careful merging of all available migraine information, lifetime diagnoses for migraine were made subject to
data availability, according to: (1) IHS ICHD-3 MO/MA
diagnostic criteria, (2) the ID MigraineTM Screener, or (3)
self-reported migraine. Hence, migraine status was measured in four categories according to these three criteria:
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FIGURE 1
The flow chart of selected twin sample.

non-migraine, self-report migraine (i.e., participants with
positive status of self-reported measurement but negative or
unknown status of the other two criteria), ID migraine (i.e.,
participants with positive status ID migraineTM Screener
criteria but negative or unknown IHS-based migraine status) and IHS migraine (i.e., participants with positive status
of IHS-based migraine). The ‘broad’ migraine status (i.e.,
any migraine) was defined when participants had reported
at least one positive migraine status; and the ‘narrow’ migraine status was strict to the IHS migraine status.
Assessment of Depression

Participants were first asked two screening questions: ‘Has
there ever been two weeks or more when you were depressed or down most of the day, nearly every day?’ and
‘Has there ever been two weeks or more when you were
a lot less interested in most things or unable to enjoy the
things you used to enjoy, most of the day, nearly every
day?’ With at least one positive response, participants then
answered additional questions (see Table 1). Lifetime depression was diagnosed according to the third and revised
edition of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-III-R; American Psychiatric Association,
1994) criteria: during a 2-week period, participants who
had positive responses of more than five symptoms were
diagnosed as suffering major depressive disorder (MDD)
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and participants who had 2–4 positive responses were diagnosed as suffering minor depressive disorder (MiDD).
Therefore, in our study, depression status was measured
in three categories: non-depression, MiDD, and MDD.
Participants with either MiDD or MDD were defined to
have the ‘broad’ depression status (i.e., any depression),
and the MDD status was used as the ‘narrow’ depression
status.
Analyses

Of the total 5,319 twin pairs included in the target sample, we stratified them into five subgroups according to sex
and zygosity: female MZ pairs, male MZ pairs, female DZ
pairs, male DZ pairs, and opposite sex DZ pairs. RRs were
calculated as the statistical ratio comparing the frequency
of a target disorder occurring in co-twins of probands and
that occurring in co-twins of health controls, which was
calculated from the cross-tabulations of proband–co-twin
pairs (see supplementary Tables S1–S6). RR for migraine
and depression was estimated in co-twins of twin probands
reporting migraine or depression to evaluate their familial
aggregation and co-occurrence.
Age at onset for migraine and depression was not available, therefore the ‘survey age’, representing the age when
subjects participated in the survey, was used to adjust for
potential age effects. To investigate whether age would
TWIN RESEARCH AND HUMAN GENETICS
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TABLE 1
The Survey Questions of IHS-Based Migraine and DSM-Based Depression
Code

Abbreviation

Question

IHS-based migraine
A
B
C1
C2

≥5 attacks
4–72 hours
Unilateral location
Pulsating quality

C3

Moderate/severe pain intensity

C4

Aggravation by physical activity

D1

Nausea and/or vomiting

D2
Aura_A

Photophobia and phonophobia
≥2 attacks with aura

Aura_B

Visual/speech/sensory aura

Aura_C1

Spreads ≥5 minutes

Aura_C2

Last 5–60 minutes

Aura_C3

Duration within 60 minutes

How many (migraine/episodes of headache) have you had during your lifetime?
On average, how long (does/did) a typical (migraine/headache) episode?
Do the headaches usually occur on one side of the head?
Would you describe the headache pain you usually experience as: throbbing,
pulsating or pounding?
Would you describe the pain associated with your headaches as: mild,
moderate, severe or unbearable?
Are your headaches aggravated by walking up or down stairs or similar routine
physical activity?
Have you ever had recurrent attacks of any of the following: nausea, vomiting
or diarrhea?
Do you experience enhanced sensitivity to light/smell?
How many headaches with these kinds of aura symptoms have you had during
your lifetime?
Have you ever had: visual disturbances lasting several minutes? Difficulties to
speak? One sided numbness or weakness?
How fast does your visual disturbance develop: the symptom is at its
worst/strongest right away (less than 1–2 minutes); or it gets worse/expands
after more than 4 minutes?
How long does your visual disturbance last: the symptom lasts less
than 1 minute; it lasts more than 1 minute but less than 1 hour; it lasts more
than 1 hour?
How visual disturbances and headache connected in time are: headaches follow
the symptom within one hour; headaches do not follow the symptom until
later; headaches and symptom occur simultaneously; or headaches come
before the symptom?

DSM-based depression
A1

Depressed mood

A2

Loss of interest

B1
B2
B3

Weight/appetite change
Sleep disturbance
Psychomotor
agitation/retardation
Fatigue/loss of energy
Worthlessness/feel guilty

B4
B5
B6
B7

Indecisiveness/diminish ability
to concentrate
Suicide attempt

Has there ever been 2 weeks or more when you were depressed or down most
of the day, nearly every day?
Has there ever been 2 weeks or more when you were a lot less interested in
most things or unable to enjoy the things you used to enjoy most of the day,
nearly every day?
Did you have a change in weight/appetite?
Did you have more trouble sleeping than usual?
Were you so fidgety or restless that you were unable to sit still?/Were you
talking or moving much more slowly than is normal for you?
Were you feeling a loss of energy or more tired than usual?
Were you feeling excessively guilty or that you were a bad person?/Were you
feeling that you were a failure or worthless?
Were you having trouble thinking or concentrating?/Was it hard to make
decisions about everyday things?
Were frequently thinking about death?

influence RR estimation, logistic regression analyses were
performed to calculate the effect of age in four analyses
(i.e., migraine in co-twins of probands reporting migraine,
depression in co-twins of probands reporting depression,
migraine in co-twins of probands reporting depression, and
depression in co-twins of probands reporting migraine).
Probands were randomly selected as the first interviewed
twin for the same-sex MZ/DZ pairs; while for the opposite
sex DZ pairs, RR estimates were obtained for selecting the
female twin as well as the male twin as proband, to estimate
cross-sex RRs.
We estimated RRs and their 95% confidence intervals
(CIs) for migraine (i.e., self-report migraine, ID migraine,
IHS migraine, and any migraine) and depression (i.e., MDD
and any depression) to assess their familial aggregation. We
then separately estimated the RRs of migraine in co-twins
of probands with depression and the RRs of depression in
co-twins of probands with migraine, for broad diagnosis
(i.e., any migraine and any depression) and narrow diagTWIN RESEARCH AND HUMAN GENETICS

nosis (i.e., IHS migraine and MDD) respectively. All the
analyses were performed using either SPSS (v22) or Rstudio (RStudio Team, 2014).

Results
Demographics

As shown in Table 2, based on 10,638 individuals (6,584
females and 4,054 males) from the twin sample, the
lifetime prevalence was estimated at 45% for any migraine and 42% for any depression. Consistent with the
previous findings (Arroyo-Quiroz et al., 2014; Bierut
et al., 1999; Buse et al., 2012; Kendler et al., 1992),
the lifetime prevalence of IHS MO/MA migraine and
DSM-III-R-based MDD was estimated at 14% and 34%
respectively. Generally, females showed higher lifetime
prevalence than males; the differences were small for selfreport migraine but increased for ID migraine and especially IHS migraine. Both any depression and MDD also

315

Yuanhao Yang et al.

TABLE 2
Lifetime Prevalence of Migraine and Depression Based on Australian Twin Sample
Migraine

Depression

Lifetime prevalence

Self-report migraine

ID migraine

IHS migraine

Any-mig

MiDD

MDD

Any-dep

Total sample
Female
Male

15.39%
15.98%
14.43%

16.07%
19.58%
10.36%

13.99%
17.68%
7.99%

45.44%
53.24%
32.78%

7.76%
7.50%
8.19%

34.30%
37.68%
28.81%

42.07%
45.19%
37.00%

Note: Any-mig = Any migraine; Any-dep = Any depression.

demonstrated higher lifetime prevalence in females than in
males, whereas the lifetime prevalence of MiDD was higher
in males compared to females.
The mean ‘survey age’ was estimated at 36±11 years,
ranging from 18 to 89 years. The logistic regressions under
all four analyses indicated that age does not significantly
influence risk for migraine and depression in our sample (p
value >.05). Therefore, we present RRs without age adjustment.
Familial Aggregation

As shown in Table 3, we observed a significantly increased
RR (RR = 1.73, 95% CI: 1.62–1.85) for any migraine in cotwins of probands reporting any migraine, compared with
co-twins of non-migraine controls. The RR for any migraine
was significantly higher within MZ pairs (RR = 2.07, 95%
CI: 1.88–2.27) compared to DZ pairs (RR = 1.47, 95% CI:
1.34–1.62). Similarly, regardless of migraine diagnosis (i.e.,
self-report migraine, ID migraine, IHS migraine, or any migraine), an increased RR was consistently found in the total
sample, and a significant higher RR was calculated within
MZ pairs compared to DZ pairs, although RRs calculated
in DZ pairs for self-report migraine and ID migraine were
not statistically significant, most likely due to their reduced
diagnostic reliability and smaller sample size. In addition,
most RRs calculated within same-sex DZ pairs were slightly
higher than those calculated within DZ opposite-sex pairs,
suggesting the presence of sex-specific effects in familial aggregation. Furthermore, RR for migraine increased in line
with the reliability of migraine diagnosis, with no significant
difference in RR between self-report migraine and ID migraine, but a significantly higher RR for IHS migraine. This
pattern of results was observed in all zygosity subgroups.
Regarding depression, although any depression comprised two types of depression, MDD and MiDD, because of
the relatively small number of MiDD patients (N = 826 participants), we focused on results for MDD and any depression. Similar to migraine, an increased RR for depression
in co-twins of probands reporting depression was observed
for both MDD (RR = 1.75, 95% CI: 1.63–1.89) and any
depression (RR = 1.53, 95% CI: 1.43–1.63) in the total
sample. These RRs significantly increased to 2.35 (95% CI:
2.10–2.62) for MDD and 1.89 (95% CI: 1.72–2.08) for any
depression in MZ pairs, and significantly decreased to 1.36
(95% CI: 1.23–1.51) for MDD and 1.27 (95% CI: 1.17–1.39)
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for any depression in DZ pairs, respectively. RRs calculated
in all zygosity subgroups also remained significant, and a
slightly higher RR was observed within same-sex DZ pairs
compared to DZ pairs. Also similar to migraine, the RRs
in DZ pairs for the narrow diagnosis (MDD) were higher
although not statistically significant, compared to RRs for
the broader any depression.
Association Between Migraine and Depression

For the broad diagnoses (Table 4) in the total sample, cotwins of probands reporting any depression had a significantly increased RR (RR = 1.18, 95% CI: 1.11–1.26) for
any migraine compared to co-twins of controls. The reverse
was also true, with the RR for any depression significantly
increased (RR = 1.12, 95% CI: 1.05–1.20) in co-twins of
probands reporting any migraine compared to co-twins of
controls, thus indicating a bi-directional association between the two disorders. The RR for any migraine in cotwins of probands reporting any depression was higher than
the reverse. The bi-directional association became more significant within MZ pairs, with an RR for any migraine in
co-twins of probands reporting any depression of 1.36 (95%
CI: 1.24–1.48) and RR for any depression in co-twins of
probands reporting any migraine was 1.26 (95% CI: 1.14–
1.38). Similar to some of the single-trait RR estimates, the
cross-trait RR estimates decreased in DZ twin pairs and became non-significant, and RRs in same-sex DZ pairs were
increased compared to opposite-sex DZ pairs. Also, significantly higher cross-trait RRs were observed within MZ
pairs compared to DZ pairs for any migraine in co-twins of
probands reporting any depression and vice versa, suggesting the presence of shared genetic components between any
migraine and any depression.
For the narrow diagnoses (Table 4), a bi-directional association between IHS migraine and MDD was also found
and was more significant compared to the broad diagnosis
in the total sample and MZ pairs. The RRs for IHS migraine in co-twins of probands reporting MDD was 1.67
(95% CI: 1.46–1.92) in the total sample and 2.23 (95% CI:
1.81–2.75) in MZ pairs; while the RRs for MDD in cotwins of probands reporting IHS migraine was 1.25 (95%
CI: 1.13–1.37) in the total sample and 1.55 (95% CI: 1.34–
1.79) in MZ pairs. In contrast, results in DZ pairs suggest
a unidirectional association, with a significant RR for IHS
migraine in co-twins of probands reporting MDD at 1.35
TWIN RESEARCH AND HUMAN GENETICS

1.53 (1.43–1.63) [5,319]
1.89 (1.72–2.08) [2,456]
1.27 (1.17–1.39) [2,863]
1.31 (1.18–1.46) [1,653]
1.89 (1.69–2.11) [1,623]
1.86 (1.55–2.22) [833]
1.14 (1.00–1.29) [1,064]
1.73 (1.42–2.11) [589]
1.23 (1.06–1.42) [1,210]
1.19 (1.05–1.34) [1,210]
1.75 (1.63–1.89) [4,534]
2.35 (2.10–2.62) [2,096]
1.36 (1.23–1.51) [2,438]
1.39 (1.23–1.58) [1,414]
2.30 (2.03–2.61) [1,401]
2.33 (1.86–2.91) [695]
1.24 (1.07–1.44) [902]
1.68 (1.32–2.14) [512]
1.33 (1.11–1.59) [1,024]
1.27 (1.09–1.47) [1,024]

TWIN RESEARCH AND HUMAN GENETICS

Note: CI = confidence interval; Any-mig = any migraine; Any-dep = any depression; DZ F–M pairs = opposite sex DZ pairs with female as probands; DZ M–F pairs = opposite sex DZ pairs
with male as probands.

Any-dep
MDD

1.73 (1.62–1.85) [5,319]
2.07 (1.88–2.27) [2,456]
1.47 (1.34–1.62) [2,863]
1.62 (1.45–1.81) [1,653]
1.85 (1.66–2.06) [1,623]
2.21 (1.82–2.69) [833]
1.49 (1.31–1.68) [1,064]
1.55 (1.23–1.94) [589]
1.25 (1.06–1.47) [1,210]
1.17 (1.04–1.31) [1,210]

Any-mig
IHS migraine

6.51 (5.57–7.62) [2,639]
10.42 (8.06–13.46) [1,176]
4.74 (3.88–5.78) [1,463]
4.35 (3.45–5.50) [844]
10.40 (7.45–4.52) [685]
8.16 (4.99–13.34) [491]
3.25 (2.52–4.19) [510]
5.46 (3.02–9.89) [334]
5.63 (3.88–8.19) [619]
3.74 (2.95–4.73) [619]
2.05 (1.75–2.39) [2,867]
2.81 (2.32–3.39) [1,391]
1.26 (0.96–1.65) [1,476]
1.45 (1.04–2.03) [806]
2.27 (1.84–2.80) [843]
3.64 (2.36–5.61) [548]
1.41 (0.99–2.02) [451]
0.66 (0.21–2.03) [355]
1.16 (0.74–1.81) [670]
1.12 (0.79–1.61) [670]
1.63 (1.38–1.91) [2,868]
2.09 (1.67–2.61) [1,349]
1.28 (1.01–1.62) [1,519]
1.55 (1.15–2.09) [841]
1.88 (1.45–2.45) [768]
2.31 (1.51–3.54) [581]
1.58 (1.09–2.28) [438]
1.42 (0.86–2.35) [403]
0.97 (0.65–1.45) [678]
0.97 (0.67–1.40) [678]
Total sample
MZ
DZ
Same-sex DZ
MZ F–F
MZ M–M
DZ F–F
DZ M–M
DZ F–M
DZ M–F

ID migraine
Self-report migraine
Sample

Migraine

Relative Risks (and 95% CI) of Single-Trait and Number of Proband–Co-Twin Pairs in Different Twin Samples

TABLE 3

Depression

Familial Aggregation of Migraine and Depression

(95% CI: 1.13–1.62) and a non-significant RR for MDD
in co-twins of probands reporting IHS migraine at 1.06
(95% CI: 0.93–1.22), respectively. Compared to DZ pairs,
MZ pairs always provided significantly higher RRs for IHS
migraine in co-twins of probands reporting MDD and the
reverse. The difference in RRs calculated in MZ and DZ pairs
was larger for the narrow diagnoses compared to the broad
diagnoses. Notably, the observed risk for IHS migraine in
co-twins of probands reporting MDD was considerably
higher than the reverse, for total sample, MZ pairs and DZ
pairs.

Discussion
Familial Aggregation of Migraine and Depression?

Previous Caucasian population-based family studies
(Cologno et al., 2003; Kalfakis et al., 1996; Lemos et al.,
2009; Russell & Olesen, 1995; Stewart et al., 1997; Stewart et al., 2006; Thomsen et al., 2003) consistently reported
familial aggregation of migraine in first-degree relatives of
probands, with highly variable RRs ranging from 1.40 to
13.82, largely due to differences in migraine types (e.g.,
MA, familial hemiplegic migraine), diagnostic approaches
(e.g., IHS-based self-report questionnaire or interview) and
sample selection. Our results from DZ pairs are equivalent to proband–first-degree RR estimates from the general population, and are in line with previous RR estimates
based on IHS migraine and any migraine status. By comparing our results for strict IHS migraine to results for the
broader definitions of migraine, self-report migraine, and
ID migraine status clearly demonstrates such expected sensitivity of RR and familial aggregation analysis of migraine
to the diagnostic approach. Our finding of significantly
higher RR for migraine within MZ pairs than DZ pairs provides strong evidence for a genetic contribution to migraine
susceptibility.
Previous studies on measuring clustering of depression
often utilized odds ratios (ORs) rather than RRs. The
OR for depression in first-degree relatives of depressive
probands have been calculated at approximately 2–3 in
Caucasian population-based family samples (Barker et al.,
2012; Merikangas et al., 2014; Schreier et al., 2006; Sullivan
et al., 2000; Vandeleur et al., 2014). Assuming a depression prevalence of between 20% and 50%, ORs ranging
from 2 to 3 are estimated to be equivalent to RRs of approximately 1.11–1.50 (using OR to Risk Ratio Conversion;
http://clincalc.com/Stats/ConvertOR.aspx). Thus, our RR
estimates for depression from DZ pairs are in agreement
with published findings, and support the familial aggregation of depression. Our finding of significantly higher RR for
depression within MZ pairs compared to DZ pairs provides
strong evidence for a genetic contribution to depression.
Although the difference in RRs between DZ F-M pairs
(opposite sex DZ pairs with female as proband) and DZ
M-F pairs (opposite sex DZ pairs with male as proband)
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TABLE 4
Relative Risks (and 95% CI) of Cross-Trait and Number of Proband–Co-Twin Pairs in Different Twin Samples
Proband–co-twin
Sample

Total sample
MZ
DZ
Same-sex DZ
MZ F–F
MZ M–M
DZ F–F
DZ M–M
DZ F–M
DZ M–F

Broad diagnosis

Narrow diagnosis

Any-dep–Any-mig

Any-mig–Any-dep

MDD–IHS migraine

IHS migraine–MDD

1.18 (1.11–1.26) [5,319]
1.36 (1.24–1.48) [2,456]
1.04 (0.95–1.14) [2,863]
1.07 (0.96–1.19) [1,653]
1.28 (1.16–1.40) [1,623]
1.52 (1.25–1.86) [833]
1.01 (0.90–1.13) [1,064]
1.08 (0.85–1.37) [589]
1.02 (0.87–1.20) [1,210]
0.97 (0.86–1.09) [1,210]

1.12 (1.05–1.20) [5,319]
1.26 (1.14–1.38) [2,456]
1.02 (0.94–1.11) [2,863]
1.06 (0.95–1.18) [1,653]
1.18 (1.06–1.32) [1,623]
1.30 (1.08–1.56) [833]
1.03 (0.90–1.16) [1,064]
0.99 (0.80–1.23) [589]
0.96 (0.83–1.12) [1,210]
1.02 (0.89–1.16) [1,210]

1.67 (1.46–1.92) [3,450]
2.23 (1.81–2.75) [1,506]
1.35 (1.13–1.62) [1,944]
1.39 (1.12–1.71) [1,082]
2.19 (1.75–2.75) [934]
1.69 (0.99–2.88) [572]
1.17 (0.94–1.46) [668]
1.81 (1.09–3.00) [414]
1.38 (0.97–1.98) [862]
1.12 (0.86–1.45) [746]

1.25 (1.13–1.37) [3,287]
1.55 (1.34–1.79) [1,473]
1.06 (0.93–1.22) [1,814]
1.04 (0.88–1.22) [1,068]
1.42 (1.21–1.66) [925]
1.46 (0.99–2.17) [548]
0.94 (0.78–1.13) [666]
1.17 (0.78–1.75) [402]
1.10 (0.88–1.38) [746]
1.22 (0.99–1.50) [862]

Note: CI = confidence interval; Any-mig: any migraine; Any-dep: any depression; DZ F–M pairs = opposite sex DZ pairs with female as probands; DZ
M–F pairs = opposite sex DZ pairs with male as probands.

for migraine and depression are not significant, the risks
for migraine and depression are consistently larger in male
co-twins of affected female probands compared to female
co-twins of affected male probands. These results suggest
the possible influence of sex-specific effects (i.e., effects expressed in one sex but not the other) that may include
genetic (G), environmental (E), and/or interacting (G×E)
effects.
Bi-Direction Association Between Migraine and Depression?

In line with previous findings (Breslau et al., 1994; Breslau
et al., 2000; Breslau et al., 2003; Modgill et al., 2012; Mongini
et al., 2003), results from analysis of broad diagnoses in the
total sample indicate a bi-directional association between
migraine and depression, with an increased RR for any migraine in co-twins of probands reporting any depression,
and vice versa. The association became stronger when analyzing the more narrow diagnoses of IHS migraine and
MDD.
The observed risk for migraine in relatives of probands
reporting depression was considerably higher than the risk
for depression in relatives of probands reporting migraine.
These results were observed for both broad and narrow diagnoses, and remained when calculating RRs by averaging
over selecting either twin 1 or twin 2 as proband, thus ensuring our results are robust to proband selection within twin
pairs. These findings provide further support to findings
from a recent analysis of single nucleotide polymorphism
(SNP) genotype data indicating that patients with comorbid migraine and depression are genetically more similar
to patients with only depression than patients with only
migraine (Ligthart et al., 2014).
Regardless of the diagnostic approach, the association
between migraine and depression was stronger within MZ
twin pairs compared to DZ pairs, thus providing strong
evidence for a genetic contribution to familial aggregation
of migraine and depression.
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Strengths and Weaknesses

Ours is the only study to use a large population-based twin
design to provide strong evidence for a genetic contribution
to the familial aggregation and co-occurrence of migraine
and depression. Another advantage of this study concerned
the utilization of multiple approaches to diagnose migraine
and depression. Comparing results from different diagnostic definitions allowed us to demonstrate both the sensitivity
and validity of RR and familial aggregation analysis of migraine and depression across different diagnostic criteria.
However, there are some limitations to note. First and
foremost, both migraine and depression status were diagnosed using self-reported questionnaire data, as opposed to
the gold-standard of clinical-based interviews by neurologists or psychologists. Although our approach may result
in some misclassification of migraine and depression status, it is not feasible to perform clinic-based interviews in
samples larger enough to provide sufficient power for such
familial aggregation studies. Moreover, our approach enabled narrow diagnoses of migraine and depression that
satisfy clinically accepted criteria. Furthermore, our estimated lifetime prevalence of IHS migraine and DSM-IIIR-based MDD are in a good agreement with published
estimates (Arroyo-Quiroz et al., 2014; Bierut et al., 1999;
Buse et al., 2012; Kendler et al., 1992). Second, we did not
separate IHS migraine into MO and MA. However, given
our previous findings indicating a strong familial aggregation and genetic overlap between MO and MA, we believe
our approach provides the most powerful and sensible use
of the data to examine the relationship between migraine
and depression. Third, probands of twin pairs were selected
randomly as the twin who first entered the survey rather
than birth order. However, considering twins essentially
share the same family environment and the fact we obtain
identical RRs and conclusions when selecting the second
(other) twin as the proband indicates our random selection
approach to be valid. Another limitation relates to our use
of ‘survey age’ rather than age of onset. However, given our
TWIN RESEARCH AND HUMAN GENETICS
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samples were comprised of adults past the typical age of
onset, and our logistic regression analyses found no association between survey age and migraine and/or depression,
we do not believe this to be an important issue.

Conclusions
In summary, this study used a large Australian populationbased twin sample and found significant evidence for a genetic contribution to the familial aggregation of migraine
and depression. Our findings also suggest a bi-directional
association between migraine and depression, with an increased risk for depression in relatives of probands reporting migraine and vice versa. However, the observed risk for
migraine in relatives of probands reporting depression was
considerably higher than the reverse. These results add further support to previous studies suggesting that patients
with comorbid migraine and depression are genetically
more similar to patients with depression compared to patients with migraine.
A better understanding of the genetic architecture of comorbid migraine and depression has excellent potential to
improve our understanding of the relationship between migraine and co-occurring depression and inform treatment
strategies. For example, identifying patients most at risk of
comorbid migraine and depression and chronic migraine
(due to medication overuse), and identifying subgroups of
patients for whom a particular treatment or treatment combination may be most effective (e.g., episodic vs. chronic migraine, depressed vs. non-depressed, those with high analgesic use). Hence, future studies should focus on characterizing and identifying the genetic and environmental factors
contributing to co-occurring migraine and depression.
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